Silk Road Medical Inc
NASDAQ:SILK
Income Statement
Earnings Waterfall
Silk Road Medical Inc
Revenue
|
177.1m
USD
|
Cost of Revenue
|
-50m
USD
|
Gross Profit
|
127.1m
USD
|
Operating Expenses
|
-186.4m
USD
|
Operating Income
|
-59.3m
USD
|
Other Expenses
|
3.5m
USD
|
Net Income
|
-55.7m
USD
|
Income Statement
Silk Road Medical Inc
Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||
Revenue |
35
N/A
|
42
+20%
|
49
+17%
|
56
+15%
|
63
+13%
|
70
+10%
|
70
+0%
|
73
+4%
|
75
+3%
|
78
+4%
|
90
+15%
|
94
+5%
|
102
+8%
|
107
+6%
|
114
+6%
|
127
+11%
|
139
+9%
|
151
+9%
|
163
+8%
|
170
+4%
|
177
+4%
|
|
Gross Profit | ||||||||||||||||||||||
Cost of Revenue |
(11)
|
(12)
|
(14)
|
(15)
|
(16)
|
(18)
|
(19)
|
(21)
|
(21)
|
(22)
|
(23)
|
(23)
|
(25)
|
(28)
|
(31)
|
(34)
|
(38)
|
(42)
|
(46)
|
(49)
|
(50)
|
|
Gross Profit |
24
N/A
|
29
+24%
|
35
+20%
|
41
+17%
|
47
+15%
|
52
+9%
|
50
-3%
|
52
+3%
|
54
+4%
|
57
+5%
|
67
+18%
|
71
+6%
|
76
+7%
|
79
+4%
|
83
+5%
|
93
+11%
|
101
+9%
|
109
+8%
|
117
+7%
|
121
+4%
|
127
+5%
|
|
Operating Income | ||||||||||||||||||||||
Operating Expenses |
(45)
|
(53)
|
(60)
|
(69)
|
(76)
|
(82)
|
(84)
|
(87)
|
(97)
|
(102)
|
(112)
|
(120)
|
(124)
|
(132)
|
(141)
|
(146)
|
(153)
|
(162)
|
(170)
|
(179)
|
(186)
|
|
Selling, General & Administrative |
(35)
|
(42)
|
(49)
|
(57)
|
(63)
|
(69)
|
(71)
|
(73)
|
(76)
|
(77)
|
(84)
|
(90)
|
(96)
|
(102)
|
(108)
|
(111)
|
(116)
|
(123)
|
(131)
|
(138)
|
(145)
|
|
Research & Development |
(10)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(21)
|
(24)
|
(27)
|
(30)
|
(27)
|
(30)
|
(33)
|
(35)
|
(36)
|
(39)
|
(39)
|
(40)
|
(41)
|
|
Operating Income |
(21)
N/A
|
(24)
-12%
|
(25)
-5%
|
(28)
-11%
|
(28)
-1%
|
(30)
-7%
|
(33)
-11%
|
(35)
-6%
|
(43)
-21%
|
(45)
-5%
|
(46)
-1%
|
(50)
-9%
|
(48)
+4%
|
(53)
-12%
|
(57)
-8%
|
(53)
+7%
|
(52)
+3%
|
(53)
-2%
|
(53)
+0%
|
(58)
-8%
|
(59)
-3%
|
|
Pre-Tax Income | ||||||||||||||||||||||
Interest Income Expense |
(4)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
0
|
2
|
3
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(12)
|
(28)
|
(31)
|
(28)
|
(21)
|
(5)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
Pre-Tax Income |
(38)
N/A
|
(56)
-50%
|
(61)
-8%
|
(60)
+2%
|
(52)
+12%
|
(38)
+27%
|
(37)
+4%
|
(39)
-6%
|
(47)
-22%
|
(48)
-2%
|
(48)
0%
|
(52)
-7%
|
(50)
+4%
|
(56)
-12%
|
(61)
-9%
|
(57)
+6%
|
(55)
+4%
|
(55)
+0%
|
(53)
+4%
|
(55)
-5%
|
(56)
-1%
|
|
Net Income | ||||||||||||||||||||||
Income from Continuing Operations |
(38)
|
(56)
|
(61)
|
(60)
|
(52)
|
(38)
|
(37)
|
(39)
|
(47)
|
(48)
|
(48)
|
(52)
|
(50)
|
(56)
|
(61)
|
(57)
|
(55)
|
(55)
|
(53)
|
(55)
|
(56)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(38)
N/A
|
(56)
-50%
|
(61)
-8%
|
(60)
+2%
|
(52)
+12%
|
(38)
+27%
|
(37)
+4%
|
(39)
-6%
|
(47)
-22%
|
(48)
-2%
|
(48)
0%
|
(52)
-7%
|
(50)
+4%
|
(56)
-12%
|
(61)
-9%
|
(57)
+6%
|
(55)
+4%
|
(55)
+0%
|
(53)
+4%
|
(55)
-5%
|
(56)
-1%
|
|
EPS (Diluted) |
-1.24
N/A
|
-1.87
-51%
|
-1.97
-5%
|
-1.94
+2%
|
-2.28
-18%
|
-1.21
+47%
|
-1.11
+8%
|
-1.15
-4%
|
-1.44
-25%
|
-1.4
+3%
|
-1.39
+1%
|
-1.51
-9%
|
-1.44
+5%
|
-1.61
-12%
|
-1.74
-8%
|
-1.63
+6%
|
-1.54
+6%
|
-1.42
+8%
|
-1.36
+4%
|
-1.42
-4%
|
-1.44
-1%
|